Risk of heart failure in patients with type 2 diabetes receiving insulin therapy: a meta-analysis of observational studies
Aim. To compare the effect of insulin therapy and oral hypoglycemic agents (OHAs) on the risk of heart failure (HF) in patients with type 2 diabetes (T2D) using different databases.Material and methods. The systematic review and meta-analysis were carried out in accordance with the Preferred Reporti...
Saved in:
Main Authors: | S. V. Mironova, N. A. Koziolova, E. V. Ulybina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2023-04-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5375 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01) -
Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01) -
Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01) -
Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
by: N. A. Koziolova, et al.
Published: (2023-04-01) -
Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review
by: Yufeng He, et al.
Published: (2025-07-01)